Dysregulation of CRMP2 post-translational modifications drive its pathological functions

A Moutal, KA White, A Chefdeville, RN Laufmann… - Molecular …, 2019 - Springer
Collapsin response mediator proteins (CRMPs) are a family of ubiquitously expressed,
homologous phosphoproteins best known for coordinating cytoskeletal formation and …

SARS-CoV-2 spike protein co-opts VEGF-A/neuropilin-1 receptor signaling to induce analgesia

A Moutal, LF Martin, L Boinon, K Gomez, D Ran… - Pain, 2021 - journals.lww.com
PAIN International Association for the Study of Pain PAIN PAIN Reports Log in or Register
Subscribe to journalSubscribe Get new issue alertsGet alerts Become an IASP Member …

Persistent sodium currents in neurons: potential mechanisms and pharmacological blockers

P Müller, A Draguhn, AV Egorov - Pflügers Archiv-European Journal of …, 2024 - Springer
Persistent sodium current (INaP) is an important activity-dependent regulator of neuronal
excitability. It is involved in a variety of physiological and pathological processes, including …

Long-lasting antinociceptive effects of green light in acute and chronic pain in rats

MM Ibrahim, A Patwardhan, KB Gilbraith, A Moutal… - Pain, 2017 - journals.lww.com
Treatments for chronic pain are inadequate, and new options are needed.
Nonpharmaceutical approaches are especially attractive with many potential advantages …

[HTML][HTML] Novel nasal niosomes loaded with lacosamide and coated with chitosan: A possible pathway to target the brain to control partial-onset seizures

AS Tulbah, MH Elkomy, RM Zaki, HM Eid… - International journal of …, 2023 - Elsevier
This work aimed to develop and produce lacosamide-loaded niosomes coated with chitosan
(LCA-CTS-NSM) using a thin-film hydration method and the Box-Behnken design. The effect …

CRISPR/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide

A Moutal, X Yang, W Li, KB Gilbraith, S Luo, S Cai… - Pain, 2017 - journals.lww.com
Abstract Neurofibromatosis type 1 (NF1) is a rare autosomal dominant disease linked to
mutations of the Nf1 gene. Patients with NF1 commonly experience severe pain. Studies on …

Inhibition of the Ubc9 E2 SUMO-conjugating enzyme–CRMP2 interaction decreases NaV1. 7 currents and reverses experimental neuropathic pain

L François-Moutal, ET Dustrude, Y Wang… - Pain, 2018 - journals.lww.com
We previously reported that destruction of the small ubiquitin-like modifier (SUMO)
modification site in the axonal collapsin response mediator protein 2 (CRMP2) was sufficient …

Blocking CRMP2 SUMOylation reverses neuropathic pain

A Moutal, ET Dustrude, TM Largent-Milnes… - Molecular …, 2018 - nature.com
Collapsin response mediator proteins 1− 5 (CRMPs1− 5) are a family of cytosolic proteins
that coordinate neuronal migration, axonal guidance, dendritic organization, dendritic spine …

Betulinic acid, derived from the desert lavender Hyptis emoryi, attenuates paclitaxel-, HIV-, and nerve injury–associated peripheral sensory neuropathy via block of N …

SS Bellampalli, Y Ji, A Moutal, S Cai, EMK Wijeratne… - Pain, 2019 - journals.lww.com
Abstract The Federal Pain Research Strategy recommended development of nonopioid
analgesics as a top priority in its strategic plan to address the significant public health crisis …

Targeting the CaVα–CaVβ interaction yields an antagonist of the N-type CaV2. 2 channel with broad antinociceptive efficacy

R Khanna, J Yu, X Yang, A Moutal, A Chefdeville… - Pain, 2019 - journals.lww.com
Inhibition of voltage-gated calcium (CaV) channels is a potential therapy for many
neurological diseases including chronic pain. Neuronal CaV1/CaV2 channels are …